Acadia Pharmaceuticals
Bob Mischler is an accomplished executive with extensive experience in strategy, business development, and commercial operations within the pharmaceutical industry. Currently serving as Senior Vice President of Strategy and Technology Operations at ACADIA Pharmaceuticals Inc. since March 2015, Bob has previously held leadership roles at Ardea Biosciences, CovX Technologies, Pfizer, and Eli Lilly, where responsibilities included scientific affairs, commercial planning, and market research. Bob's educational background includes an MBA from UCLA Anderson School of Management and a Bachelor's degree in Biology from Indiana University Bloomington.
Acadia Pharmaceuticals
3 followers
Acadia is trailblazing breakthroughs in neuroscience to elevate life. They are at the forefront of healthcare, fighting for breakthroughs in our science, their therapies and the way we work, but also in the lives of the people they serve. Acadia is committed to their purpose: we fight disease so more you shines through.